TWi Biotechnology, Inc. (TPEX:6610)
36.70
+3.85 (11.72%)
Sep 26, 2025, 2:59 PM CST
TWi Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -155.28 | -164.81 | -170.68 | -76.18 | -15.3 | -101.86 | Upgrade
|
Depreciation & Amortization | 9.67 | 9.7 | 9.74 | 10.33 | 11.08 | 11.43 | Upgrade
|
Other Amortization | - | - | 0 | 0.02 | 0.02 | 0.24 | Upgrade
|
Stock-Based Compensation | -0 | -0.88 | 5.5 | 3.08 | - | - | Upgrade
|
Other Operating Activities | - | - | -0.01 | - | - | 0.03 | Upgrade
|
Change in Accounts Receivable | -0.45 | -0.45 | 0.13 | 3.56 | -3.41 | 7.02 | Upgrade
|
Change in Inventory | - | - | - | - | 2.34 | 0.4 | Upgrade
|
Change in Accounts Payable | - | - | - | - | - | -5.19 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -30.07 | 32.82 | Upgrade
|
Change in Other Net Operating Assets | 15.14 | 1.02 | 21.1 | -1.06 | 0.87 | -7.48 | Upgrade
|
Operating Cash Flow | -130.92 | -155.41 | -134.22 | -60.24 | -34.46 | -62.58 | Upgrade
|
Capital Expenditures | -0.15 | -0.31 | - | - | -0.23 | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | - | - | -30 | -30 | Upgrade
|
Investment in Securities | 32.13 | 123.05 | -171.85 | 34.3 | 191.9 | 101.82 | Upgrade
|
Other Investing Activities | -0.03 | - | - | - | -0.03 | - | Upgrade
|
Investing Cash Flow | 31.95 | 122.75 | -171.85 | 34.3 | 161.64 | 71.82 | Upgrade
|
Short-Term Debt Issued | - | 10 | - | - | 7.6 | - | Upgrade
|
Total Debt Issued | 10 | 10 | - | - | 7.6 | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -7.6 | - | Upgrade
|
Long-Term Debt Repaid | - | -2.37 | -2.5 | -2.5 | -2.46 | -2.48 | Upgrade
|
Total Debt Repaid | -12.63 | -2.37 | -2.5 | -2.5 | -10.06 | -2.48 | Upgrade
|
Net Debt Issued (Repaid) | -2.63 | 7.63 | -2.5 | -2.5 | -2.46 | -2.48 | Upgrade
|
Issuance of Common Stock | 235.87 | - | 300 | - | - | - | Upgrade
|
Financing Cash Flow | 233.24 | 7.63 | 297.5 | -2.5 | -2.46 | -2.48 | Upgrade
|
Net Cash Flow | 134.27 | -25.04 | -8.57 | -28.44 | 124.72 | 6.76 | Upgrade
|
Free Cash Flow | -131.07 | -155.72 | -134.22 | -60.24 | -34.69 | -62.58 | Upgrade
|
Free Cash Flow Margin | - | - | - | - | -52.24% | -5022.39% | Upgrade
|
Free Cash Flow Per Share | -1.49 | -1.78 | -1.83 | -0.89 | -0.51 | -0.93 | Upgrade
|
Cash Interest Paid | 0.13 | 0.16 | 0.09 | 0.05 | 0.09 | 0.02 | Upgrade
|
Cash Income Tax Paid | - | - | - | - | - | 1.35 | Upgrade
|
Levered Free Cash Flow | -17.59 | -134.11 | -68.48 | -40.34 | -88.91 | -5.83 | Upgrade
|
Unlevered Free Cash Flow | -17.51 | -134.02 | -68.43 | -40.31 | -88.85 | -5.82 | Upgrade
|
Change in Working Capital | 14.69 | 0.57 | 21.24 | 2.5 | -30.26 | 27.58 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.